News

Evolv and Valor: A Pioneering Partnership in Payment Solutions

Evolv and Valor: A Pioneering Partnership in Payment Solutions

Evolv and Valor: A Partnership Driving Payment Innovation

Evolv, a leader in advanced payment acceptance solutions, proudly highlights its ongoing partnership with Valor PayTech, a top provider of point-of-sale technology. This strategic alliance has been pivotal in delivering customized payment solutions, branded as EvolvPay, which empower merchants through seamless, state-of-the-art technology.

Background of Evolv and Its Commitment to Innovation

Founded in 1998, Evolv has established itself as a trusted name in enhancing merchant operations. With a mission to increase sales and streamline costs while minimizing risks, Evolv has developed a wide array of payment products, including point-of-sale systems, gateways, and terminals. In a significant move to expand its offerings, Evolv invested in VIV, a digital marketing agency, in 2017, enabling them to provide integrated web development and advertising services alongside their payment solutions.

Valor PayTech: Revolutionizing Point-of-Sale Technology

Valor PayTech stands out for its innovation in POS technology and its impressive record of processing over $2 billion in transactions. With more than 110 shopping cart integrations and a global network of over 250,000 connected devices, Valor tailors its solutions to fit the unique needs of merchants, thereby remaining at the forefront of industry trends.

Strengthening Collaboration for Greater Impact

Allan Noe, CEO & President of Evolv, shared insights into the partnership: "Valor has been more than just a technology partner—they've been integral to our growth. As our Platinum Partner during our annual sales summit, they've not only supported us but also enhanced our understanding of their platform. This cooperation enables us to offer a fully branded, tailored solution—EvolvPay—specifically designed for our merchant clients."

Shared Vision for Superior Payment Solutions

Eric Bernstein, CEO of Valor PayTech, expressed a shared enthusiasm for the collaboration: "Evolv embodies all the qualities we seek in a partner—customer-centric, growth-oriented, and innovative. Our collaboration has led to a truly customized and scalable solution, and it’s inspiring to witness EvolvPay continuously elevate our expectations for payment technology."

Looking Forward: The Future of Evolv and Valor

The Evolv and Valor partnership continues to make significant strides in redefining the payment landscape through innovation and dedication to excellence. Together, they deliver superior technology, outstanding service, and unrivaled value to both partners and merchants.

Frequently Asked Questions

What is the core focus of the partnership between Evolv and Valor?

The partnership is centered around providing innovative, customized payment solutions to empower merchants through advanced technology.

When was the partnership between Evolv and Valor established?

The strategic alliance was formed in 2021 and has since evolved to enhance payment technology offerings.

What are some key offerings of Evolv?

Evolv offers a range of payment products including POS systems, gateways, and terminals, alongside integrated marketing services.

How has Valor PayTech contributed to the partnership?

Valor has provided tailored payment technologies and has supported Evolv through sponsorship and active collaboration.

What is EvolvPay?

EvolvPay is a customized payment solution developed through the partnership that aims to cater specifically to the needs of merchants.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation Alerts for Spyre Therapeutics Investors Amid Concerns

Updated Category News Views 143

Investigation of Claims for Spyre Therapeutics Investors Pomerantz LLP is currently investigating claims on behalf of investors of Spyre Therapeutics, Inc. (NASDAQ: SYRE). The firm seeks to understand whether Spyre and its executives have potentially engaged in any unlawful business practices, specifically concerning securities fraud. Understanding the Securities Concerns...

Continue Reading
Natixis CIB's Pioneering Project Financing for Infrastructure

Updated Category News Views 126

Natixis CIB's Role in Groundbreaking Project Financing Natixis Corporate & Investment Banking (Natixis CIB) has taken a significant step in enhancing infrastructure development by serving as Joint Bookrunner and Joint Lead Arranger for a remarkable $281 million project financing. This financing initiative will support Ruta del Este, a concessionaire formed by ISA Vías to...

Continue Reading
Finch Therapeutics Moves to Delist from Nasdaq Amid Challenges

Updated Category News Views 177

Finch Therapeutics Plans Delisting from Nasdaq Finch Therapeutics Group, Inc. (Nasdaq: FNCH) has recently announced its decision to delist from The Nasdaq Stock Market, LLC. This move is part of a broader strategy aimed at navigating current market challenges and optimizing operational efficiency. The company is a leader in microbiome technology, boasting a strong...

Continue Reading
ModivCare: Exploring Recent Developments and Stockholder Rights

Updated Category News Views 269

Investigating the Latest Events Surrounding ModivCare Recent events surrounding ModivCare, Inc. have drawn considerable attention from the investor community and law firms alike. This scrutiny comes after a class action lawsuit from long-term shareholders, alleging the company's management may have misled investors about its ability to manage its financial health during a...

Continue Reading
Investors in Avantor, Inc. Urged to Act Before Key Deadline

Updated Category News Views 157

A Call to Action for Avantor, Inc. Investors Investors in Avantor, Inc. should take heed of an essential notification regarding a securities class action. As a market participant interested in Avantor, Inc. (NYSE: AVTR), your involvement could be crucial. This class action centers around stock purchases made during a specific timeframe that is intended to hold the company...

Continue Reading